http://jcps.bjmu.edu.cn

Journal of Chinese Pharmaceutical Sciences ›› 2017, Vol. 26 ›› Issue (4): 291-297.DOI: 10.5246/jcps.2017.04.030

• Original articles • Previous Articles     Next Articles

Pharmacokinetics and bioequivalence analysis of amlodipine tablets in Chinese female and male volunteers by HPLC-MS/MS

Sisi Cao1,2,3, Yang Deng1,4, Hualin Cai1,2, Zhenyan Hou1,2, Miao Yan1,2*, Bikui Zhang1,2*   

  1. 1. Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha 410011, China
    2. Institute of Clinical Pharmacy, Central South University, Changsha 410011, China
    3. School of Pharmaceutical Sciences, Central South University, Changsha 410013, China
    4. Pharmaceutical College, Hunan University of Chinese Medicine, Changsha 410028, China
  • Received:2017-01-04 Revised:2017-02-18 Online:2017-04-26 Published:2017-03-28
  • Contact: Tel./Fax: +86-731-85292098, E-mail: zhbk68@163.com

Abstract:

In the present study, we determined the pharmacokinetics and bioequivalence of two amlodipine tablets in Chinese male and female volunteers using HPLC-MS/MS method. A randomized, two-period and crossover design was conducted in 20 healthy volunteers (14 male subjects and six female subjects). A single dose of either the reference or test formulation was given at the start of each period. Blood samples were collected before drug administration and at 1, 2, 3, 4, 5, 6, 8, 10, 12, 24, 48, 72, 96, 120 and 144 h after drug administration. Plasma amlodipine was detected by HPLC-MS/MS method, and the pharmacokinetic parameters were analyzed using DAS 3.2.8. The developed HPLC-MS/MS method was suitable for the analysis of amlodipine in biological matrix samples. The main pharmacokinetic parameters between the trial preparation and the reference preparation met the regulatory criteria for bioequivalence, and the two preparations were both well tolerated.

Key words: Amlodipine, Pharmacokinetics, Bioequivalence, Tolerability, HPLC-MS/MS

CLC Number: 

Supporting: